CymaBay Therapeutics CBAY
$ 32.48
0.0%
Annual report 2023
added 02-28-2024
CymaBay Therapeutics Cash Flow 2011-2024 | CBAY
Annual Cash Flow CymaBay Therapeutics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-72.5 M | -84.1 M | -69.4 M | -44.7 M | -97.9 M | -54.9 M | -19.6 M | -23.4 M | - | - | -8.46 M | -11.3 M | - |
Depreciation & Amortization |
681 K | 625 K | 669 K | 632 K | 572 K | 105 K | 35 K | 29 K | 22 K | 18 K | 55 K | 119 K | - |
Accounts Payables |
3.83 M | 1.1 M | 2.73 M | 231 K | 2.5 M | 1.97 M | 1.31 M | 899 K | 1.01 M | 2.08 M | 697 K | - | - |
Accounts Receivables |
- | - | - | 277 K | 687 K | - | 5 M | - | - | 211 K | 110 K | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow CymaBay Therapeutics
2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | 6.43 M | - | -65.3 M | -47.8 M | -25.4 M | - | -55.2 M | -39.8 M | -20.6 M | - | -29.9 M | -22.5 M | -14.7 M | - | -69.8 M | -46.6 M | -22.4 M | - | -35.3 M | -19.3 M | -6.44 M | - | -13.6 M | -8.09 M | - | - | - | - | - | - | - | - | - | - | - | - | -5.01 M | - | - | - | -2.16 M | - | -10.9 M | - | - | - | - | - | - |
Depreciation & Amortization |
- | - | 199 K | - | 525 K | 343 K | 169 K | - | 515 K | 339 K | 164 K | - | 468 K | 309 K | 153 K | - | 422 K | 278 K | 138 K | - | 39 K | 25 K | 12 K | - | 26 K | 18 K | 9 K | - | 21 K | 11 K | 5 K | - | 17 K | 11 K | 6 K | - | 13 K | 8 K | 3 K | - | 50 K | 41 K | 26 K | - | 91 K | - | - | - | - | - | - |
Accounts Payables |
2.73 M | 4.59 M | 1.63 M | 1.1 M | 479 K | 866 K | 199 K | 2.73 M | 764 K | 1.05 M | 1.61 M | 231 K | 231 K | 231 K | 231 K | 2.5 M | 2.5 M | 2.5 M | 2.5 M | 1.97 M | 1.97 M | 1.97 M | 1.97 M | 1.31 M | 1.31 M | 1.31 M | 1.31 M | 899 K | 899 K | 899 K | 899 K | 1.01 M | 1.01 M | 1.01 M | 1.01 M | 2.08 M | 2.08 M | 2.08 M | 2.08 M | 697 K | 697 K | 697 K | 697 K | 657 K | 657 K | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | 69 K | 227 K | 265 K | 277 K | 284 K | 277 K | 277 K | 687 K | 687 K | 687 K | 687 K | 304 K | 304 K | 304 K | 304 K | 5 M | 5 M | 5 M | 5 M | - | - | - | - | - | - | 17 K | - | 211 K | 211 K | 211 K | 211 K | 110 K | 110 K | 110 K | 110 K | 108 K | 108 K | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency